Literature DB >> 20509598

Facile synthesis of advanced photodynamic molecular beacon architectures.

Jonathan F Lovell1, Juan Chen, Elizabeth Huynh, Mark T Jarvi, Brian C Wilson, Gang Zheng.   

Abstract

Nucleic acid photodynamic molecular beacons (PMBs) are a class of activatable photosensitizers that increase singlet oxygen generation upon binding a specific target sequence. Normally, PMBs are functionalized with multiple solution-phase labeling and purification steps. Here, we make use of a flexible solid-phase approach for completely automated synthesis of PMBs. This enabled the creation of a new type of molecular beacon that uses a linear superquencher architecture. The 3' terminus was labeled with a photosensitizer by generating pyropheophorbide-labeled solid-phase support. The 5' terminus was labeled with up to three consecutive additions of a dark quencher phosphoramidite. These photosensitizing and quenching moieties were stable in the harsh DNA synthesis environment and their hydrophobicity facilitated PMB purification by HPLC. Linear superquenchers exhibited highly efficient quenching. This fully automated synthesis method simplifies not only the synthesis and purification of PMBs, but also the creation of new activatable photosensitizer designs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20509598     DOI: 10.1021/bc100178z

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

1.  Optically controlled release of DNA based on nonradiative relaxation process of quenchers.

Authors:  Yusuke Ogura; Atsushi Onishi; Takahiro Nishimura; Jun Tanida
Journal:  Biomed Opt Express       Date:  2016-05-09       Impact factor: 3.732

2.  Emerging applications of porphyrins in photomedicine.

Authors:  Haoyuan Huang; Wentao Song; James Rieffel; Jonathan F Lovell
Journal:  Front Phys       Date:  2015-04-10

Review 3.  Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Anne-Laure Bulin; Girgis Obaid; Megumi Ichikawa; Tayyaba Hasan
Journal:  Theranostics       Date:  2016-10-23       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.